SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 589.32 |
| Enterprise Value ($M) | 562.79 |
| Book Value ($M) | 106.89 |
| Book Value / Share | 0.56 |
| Price / Book | 5.51 |
| NCAV ($M) | 99.23 |
| NCAV / Share | 0.52 |
| Price / NCAV | 5.94 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.67 |
| Return on Assets (ROA) | -0.53 |
| Return on Equity (ROE) | -0.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.02 |
| Current Ratio | 7.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 132.78 |
| Assets | 140.44 |
| Liabilities | 33.55 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Roivant Sciences Ltd. | 20.50 | 0.00 | |
| 13D/A | Whitefort Capital Master Fund, LP | 7.00 | ||
| 13G/A | Morgan Stanley | 11.40 | 10.99 | |
| 13G/A | Two Seas Capital LP | 4.40 | -7.24 | |
| 13D/A | Whitefort Capital Management, LP | 6.80 | ||
| 13G/A | BlackRock, Inc. | 6.20 | 19.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 218,612 | 721,549 | 30.30 | |
| 240,348 | 950,125 | 25.30 | |
| 228,754 | 1,085,648 | 21.07 | |
| 631,137 | 1,226,179 | 51.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
| ACAD – ACADIA Pharmaceuticals Inc. | ACLX – Arcellx, Inc. |